RU2005121554A - Хиральные арилкетоны в лечении нейтрофил-зависимых воспалительных заболеваний - Google Patents
Хиральные арилкетоны в лечении нейтрофил-зависимых воспалительных заболеваний Download PDFInfo
- Publication number
- RU2005121554A RU2005121554A RU2005121554/04A RU2005121554A RU2005121554A RU 2005121554 A RU2005121554 A RU 2005121554A RU 2005121554/04 A RU2005121554/04 A RU 2005121554/04A RU 2005121554 A RU2005121554 A RU 2005121554A RU 2005121554 A RU2005121554 A RU 2005121554A
- Authority
- RU
- Russia
- Prior art keywords
- phenyl
- isobutylphenyl
- methyl
- oxopentanoate
- oxobutyl
- Prior art date
Links
- 208000027866 inflammatory disease Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract 7
- 239000003814 drug Substances 0.000 claims abstract 4
- 108090001007 Interleukin-8 Proteins 0.000 claims abstract 3
- 201000010099 disease Diseases 0.000 claims abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract 3
- 201000004681 Psoriasis Diseases 0.000 claims abstract 2
- 230000006378 damage Effects 0.000 claims abstract 2
- 229940079593 drug Drugs 0.000 claims abstract 2
- 208000028867 ischemia Diseases 0.000 claims abstract 2
- 230000010410 reperfusion Effects 0.000 claims abstract 2
- 206010039073 rheumatoid arthritis Diseases 0.000 claims abstract 2
- -1 C 1 -C 4 acyloxy Chemical group 0.000 claims 18
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 7
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- HHVIBTZHLRERCL-UHFFFAOYSA-N sulfonyldimethane Chemical compound CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 claims 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 2
- 230000035605 chemotaxis Effects 0.000 claims 2
- 229960001760 dimethyl sulfoxide Drugs 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- MDDHXQWPMRKRBD-GFCCVEGCSA-N (2r)-2-[4-(2-methylpropyl)phenyl]pentan-3-one Chemical compound CCC(=O)[C@H](C)C1=CC=C(CC(C)C)C=C1 MDDHXQWPMRKRBD-GFCCVEGCSA-N 0.000 claims 1
- UUTXGQUXLKVJCL-QGZVFWFLSA-N (2r)-3-oxo-2-[4-(3-oxo-1h-isoindol-2-yl)phenyl]pentanamide Chemical compound C1=CC([C@@H](C(N)=O)C(=O)CC)=CC=C1N1C(=O)C2=CC=CC=C2C1 UUTXGQUXLKVJCL-QGZVFWFLSA-N 0.000 claims 1
- MKJYJOWDXMMVHD-KRWDZBQOSA-N (2r)-3-oxo-2-[4-(3-oxo-1h-isoindol-2-yl)phenyl]pentanenitrile Chemical compound C1=CC([C@H](C#N)C(=O)CC)=CC=C1N1C(=O)C2=CC=CC=C2C1 MKJYJOWDXMMVHD-KRWDZBQOSA-N 0.000 claims 1
- SGZQOTMMVLQDFL-LBPRGKRZSA-N (3r)-3-(3-benzoylphenyl)butan-2-one Chemical compound CC(=O)[C@H](C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 SGZQOTMMVLQDFL-LBPRGKRZSA-N 0.000 claims 1
- VOYZJYGIHFRNAG-NSHDSACASA-N (3r)-3-[4-(2-methylpropyl)phenyl]butan-2-one Chemical compound CC(C)CC1=CC=C([C@@H](C)C(C)=O)C=C1 VOYZJYGIHFRNAG-NSHDSACASA-N 0.000 claims 1
- SGZQOTMMVLQDFL-GFCCVEGCSA-N (3s)-3-(3-benzoylphenyl)butan-2-one Chemical compound CC(=O)[C@@H](C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 SGZQOTMMVLQDFL-GFCCVEGCSA-N 0.000 claims 1
- VOYZJYGIHFRNAG-LLVKDONJSA-N (3s)-3-[4-(2-methylpropyl)phenyl]butan-2-one Chemical compound CC(C)CC1=CC=C([C@H](C)C(C)=O)C=C1 VOYZJYGIHFRNAG-LLVKDONJSA-N 0.000 claims 1
- SMPOYUDSLNFLFV-QGZVFWFLSA-N (4r)-4-[4-(2-methylpropyl)phenyl]-1-phenylpentan-3-one Chemical compound C1=CC(CC(C)C)=CC=C1[C@@H](C)C(=O)CCC1=CC=CC=C1 SMPOYUDSLNFLFV-QGZVFWFLSA-N 0.000 claims 1
- GOMZQENQNXLCMQ-MRXNPFEDSA-N (4r)-4-[4-(2-methylpropyl)phenyl]-1-pyridin-3-ylpentan-3-one Chemical compound C1=CC(CC(C)C)=CC=C1[C@@H](C)C(=O)CCC1=CC=CN=C1 GOMZQENQNXLCMQ-MRXNPFEDSA-N 0.000 claims 1
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 1
- KBIMNCFEKCAFJN-UHFFFAOYSA-N 1-dimethoxyphosphoryl-3-[4-(2-methylpropyl)phenyl]butan-2-one Chemical compound COP(=O)(OC)CC(=O)C(C)C1=CC=C(CC(C)C)C=C1 KBIMNCFEKCAFJN-UHFFFAOYSA-N 0.000 claims 1
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims 1
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 claims 1
- 206010009900 Colitis ulcerative Diseases 0.000 claims 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 claims 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- 206010016654 Fibrosis Diseases 0.000 claims 1
- 206010018364 Glomerulonephritis Diseases 0.000 claims 1
- 241000721454 Pemphigus Species 0.000 claims 1
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 1
- 208000027418 Wounds and injury Diseases 0.000 claims 1
- 125000001931 aliphatic group Chemical group 0.000 claims 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims 1
- 125000001231 benzoyloxy group Chemical group C(C1=CC=CC=C1)(=O)O* 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 150000003857 carboxamides Chemical class 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 125000004122 cyclic group Chemical group 0.000 claims 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
- KZTYYGOKRVBIMI-UHFFFAOYSA-N diphenyl sulfone Chemical compound C=1C=CC=CC=1S(=O)(=O)C1=CC=CC=C1 KZTYYGOKRVBIMI-UHFFFAOYSA-N 0.000 claims 1
- DDFQJXGXFPCKDO-AWEZNQCLSA-N ethyl (4s)-4-(3-benzoylphenyl)-3-oxopentanoate Chemical compound CCOC(=O)CC(=O)[C@@H](C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DDFQJXGXFPCKDO-AWEZNQCLSA-N 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 230000004761 fibrosis Effects 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 208000014674 injury Diseases 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- LEEMRUWMBTVSBL-LBPRGKRZSA-N methyl (4S)-4-[4-(2-methylpropyl)phenyl]-3-oxopentanoate Chemical compound COC(=O)CC(=O)[C@@H](C)C1=CC=C(CC(C)C)C=C1 LEEMRUWMBTVSBL-LBPRGKRZSA-N 0.000 claims 1
- BVCPYUQEGQXBFK-CYBMUJFWSA-N methyl (4r)-4-(3-benzoylphenyl)-3-oxopentanoate Chemical compound COC(=O)CC(=O)[C@H](C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 BVCPYUQEGQXBFK-CYBMUJFWSA-N 0.000 claims 1
- LEEMRUWMBTVSBL-GFCCVEGCSA-N methyl (4r)-4-[4-(2-methylpropyl)phenyl]-3-oxopentanoate Chemical compound COC(=O)CC(=O)[C@H](C)C1=CC=C(CC(C)C)C=C1 LEEMRUWMBTVSBL-GFCCVEGCSA-N 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 1
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- YRBDAXYIDSJKAT-QGZVFWFLSA-N tert-butyl n-[(6r)-6-[4-(2-methylpropyl)phenyl]-5-oxoheptyl]carbamate Chemical compound CC(C)CC1=CC=C([C@@H](C)C(=O)CCCCNC(=O)OC(C)(C)C)C=C1 YRBDAXYIDSJKAT-QGZVFWFLSA-N 0.000 claims 1
- 208000025865 Ulcer Diseases 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 230000008595 infiltration Effects 0.000 abstract 1
- 238000001764 infiltration Methods 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 210000000440 neutrophil Anatomy 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/18—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
- C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/24—Sulfones; Sulfoxides having sulfone or sulfoxide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
- C07C45/562—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with nitrogen as the only hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
- C07C45/676—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton by elimination of carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/213—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/213—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing six-membered aromatic rings
- C07C49/215—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing six-membered aromatic rings polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/782—Ketones containing a keto group bound to a six-membered aromatic ring polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4056—Esters of arylalkanephosphonic acids
- C07F9/4059—Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Peptides Or Proteins (AREA)
- Indole Compounds (AREA)
- Pyridine Compounds (AREA)
Claims (7)
1. Применение (R,S)-1-арилэтилкетонов формулы I и их идивидуальных (R) и (S) энантиомеров
где Ar представляет собой фенил, необязательно замещенный от одного до трех заместителей, которые могут быть одинаковыми или отличаться друг от друга, выбранными из
галогена, С1-С4-алкила, С1-С4-алкокси, гидрокси, С1-С4-ацилокси, фенокси, циано, нитро, амино, С1-С4-ациламино, галоген-С1-С3-алкила, галоген-С1-С3-алкокси, бензоила;
или Ar представляет собой 4-тиеноилфенил, 4-(1-оксо-2-изоиндолинил)фенил, 3-хлор-4-(2,5-дигидро-1Н-пиррол-1-ил)фенил, 6-метокси-β-нафтил, 1-гидроксифенил-1-метил;
или Ar представляет собой группу формулы (III)
где А представляет собой бензил, фенокси, бензоил, бензоилоксим, 1-гидроксифенил-1-метил; В представляет собой гидрокси, С1-С4-ацилокси или группу формулы -О-С(=S)-N(СН3)2, или -S-С(=О)-N(СН3)2;
Ra и Rb независимо выбраны из группы, включающей водород, линейный или разветвленный С1-С6-алкил, фенил, α- или β-нафтил, 2,3,4-пиридил, С1-С4-алкилфенил, С1-С4-алкил(α- или β-нафтил), С1-С4-алкил(2,3,4-пиридил), циано (-CN), карбоксамид, карбоксил или карбоксиэфиры формулы CO2R", в которой R" представляет собой остаток линейного или разветвленного алифатического С1-С6-спирта, фосфонат PO(OR")2, где R" имеет вышеуказанные значения, или группу формулы Х-(СН2)n-Z, где Х представляет собой СО, SO или SO2 группу; Z представляет собой водород, трет-бутил, изопропил, CO2R", CN, фенил, α- или β-нафтил, 2,3,4-пиридил, С3-С6-циклоалкил, NH-BOC, NH2; n равно нулю или целому числу от 1 до 3;
или Ra и Rb вместе с атомом углерода, к которому они присоединены, образуют циклический остаток 2,2-дизамещенный 4,6-диоксо-1,3-диоксанил формулы II
где R' представляет собой метил или этил, или две группы R' образуют циклогексановое или циклопентановое кольцо,
для изготовления лекарственного препарата для лечения заболеваний, которые связаны с хемотаксисом PMN человека, вызванным ИЛ-8.
2. Применение по п.1, где в соединении Ar представляет собой группу 4-изобутилфенил, 3-бензоилфенил, 5-бензоилфенил, 2-ацетоксифенил, 3-феноксифенил.
3. Применение по п.1 или 2, где соединение выбрано из:
метил-(R)(-)-4-[(4'-изобутил)фенил]-3-оксопентаноат;
метил-(S)(+)-4-[(4'-изобутил)фенил]-3-оксопентаноат;
(R,S)-4-[(4'-изобутил)фенил]-3-оксопентановая кислота;
метил-(R)(-)-4-[(3'-бензоил)фенил]-3-оксопентаноат;
(R)(-)-3-[(4'-изобутил)фенил]бутан-2-он;
(S)(+)-3-[(4'-изобутил)фенил]бутан-2-он;
(R)(-)-3-[(3'-бензоил)фенил]бутан-2-он;
(R)(-)-диметил-3-(4-изобутилфенил)-2-оксобутан-1-фосфонат;
(S)(±)-диметил-3-(3'-феноксифенил)-2-оксобутил-1-фосфонат;
(R)(-)-2-(4-изобутилфенил)пентан-3-он;
(S)(+)-этил-4-[(3'-бензоил)фенил]-3-оксопентаноат;
(S)(+)-3-[(3'-бензоил)фенил]бутан-2-он;
(R)(-)-2-[(4-изобутилфенил)-4-фенилбутан-3-он;
(R)(-)-2-(4-изобутилфенил)-5-фенилпентан-3-он;
(R)(-)-2-(4-изобутилфенил)-5-(пирид-3-ил)-пентан-3-он;
(R,S)-5-(4'-изобутилфенил)гексан-2,4-дион;
(R,S)-1-фенил-5-(4'-изобутилфенил)-2,4-гександион;
(R,S)-1-(пирид-2-ил)-4-(4'-изобутилфенил)-1,3-пентандион;
(R)(-)-2-(4-изобутилфенил)-7-трет-бутоксикарбониламиногептан-3-он;
(R,S)-2-(4'-изобутилфенил)-3-оксобутил, метилсульфоксид;
(R,S)-2-(3'-бензоилфенил)-3-оксобутил, метилсульфоксид;
(R,S)-2-(4'-изобутилфенил)-3-оксобутил, метилсульфон;
(R,S)-2-(3'-бензоилфенил)-3-оксобутил, метилсульфон;
(R,S)-2-(3'-феноксифенил)-3-оксобутил, метилсульфон;
(R,S)-2-(4'-изобутилфенил)-3-оксобутил, фенилсульфон;
(R)(-)-4-(4'-пиридил)-2-[(4"-изобутил)фенил]бутан-3-он;
(R)(+)-5-[2-(4-изобутилфенил)пропион-1-ил]-2,2-диметил-1,3-диоксан-4,6-дион;
(R)(-)-5-[2-(3'-бензоилфенил)пропион-1-ил]-2,2-диметил-1,3-диоксан-4,6-дион;
(R)-2-[4-(1-оксо-2-изоиндолинил)фенил]-3-оксовалерамид;
(R)-2-[4-(1-оксо-2-изоиндолинил)фенил]-3-оксовалеронитрил.
4. Применение соединений
(R)(-)-метил-4-[(4'-бензоилокси)фенил]-3-оксопентаноат;
(R)(-)-метил-4-[(4'-изопропилсульфонилокси)фенил]-3-оксопентаноат; и
(R)(-)-метил-4-{[(4'-(2"-этил)фенилсульфониламино]фенил}-3-оксопентаноат
для изготовления лекарственного препарата для лечения заболеваний, которые связаны с хемотаксисом PMN человека, вызванным ИЛ-8.
5. Применение по п.1 или 2, где в соединении пространственная конфигурация атома углерода, к которому присоединена группа Ar, соответствует (R) энантиомеру.
6. Фармацевтическая композиция, содержащая соединение по любому из пп.1-5 в смеси с подходящим носителем.
7. Применение соединений, охарактеризованных в любом из пп.1-5, для изготовления лекарственных препаратов для лечения псориаза, ревматоидного артрита, язвенного колита, острого респираторного дистресс-синдрома (ARDS), идиопатического фиброза, гломерулонефрита, буллезной пузырчатки, и для профилактики и лечения повреждений, вызванных ишемией и реперфузией.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02027453.6 | 2002-12-10 | ||
EP02027453 | 2002-12-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2005121554A true RU2005121554A (ru) | 2006-01-20 |
RU2345759C2 RU2345759C2 (ru) | 2009-02-10 |
Family
ID=32479711
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2005121554/04A RU2345759C2 (ru) | 2002-12-10 | 2003-12-09 | Применение хиральных арилкетонов в лечении нейтрофил-зависимых воспалительных заболеваний |
Country Status (17)
Country | Link |
---|---|
US (2) | US20060247297A1 (ru) |
EP (1) | EP1581474B1 (ru) |
JP (1) | JP5021169B2 (ru) |
CN (1) | CN100383110C (ru) |
AT (1) | ATE406343T1 (ru) |
AU (1) | AU2003289993B8 (ru) |
CA (1) | CA2507765C (ru) |
CY (1) | CY1108596T1 (ru) |
DE (1) | DE60323264D1 (ru) |
DK (1) | DK1581474T3 (ru) |
ES (1) | ES2312834T3 (ru) |
HK (1) | HK1085721A1 (ru) |
NO (1) | NO332223B1 (ru) |
PT (1) | PT1581474E (ru) |
RU (1) | RU2345759C2 (ru) |
SI (1) | SI1581474T1 (ru) |
WO (1) | WO2004052830A1 (ru) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109928868A (zh) * | 2019-03-22 | 2019-06-25 | 河北科技大学 | 1,3-双(2,5-二甲基苯基)丙-2-酮的合成方法及其应用 |
CN115894198B (zh) * | 2022-11-04 | 2024-05-17 | 浙江永太科技股份有限公司 | Qulipta的关键中间体1-(2,3,6-三氟苯基)丙烷-2-酮的制备方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL125956C (ru) * | 1960-07-26 | |||
US3591350A (en) * | 1968-06-17 | 1971-07-06 | M & T Chemicals Inc | Novel plating process |
SE385883B (sv) * | 1972-04-10 | 1976-07-26 | Ciba Geigy Ag | Forfarande for framstellning av nya pyridinkarbonsyraestrar |
JPS5842851B2 (ja) | 1976-03-05 | 1983-09-22 | 三井東圧化学株式会社 | 2−(4′−アルキルフエニル)プロピオン酸の製造方法 |
US4151172A (en) | 1977-08-11 | 1979-04-24 | E. R. Squibb & Sons, Inc. | Phosphonoacyl prolines and related compounds |
JPS5697249A (en) | 1979-12-30 | 1981-08-05 | Ota Seiyaku Kk | Preparation of 2-arylalkane acid |
JP2782359B2 (ja) | 1989-06-22 | 1998-07-30 | 日本石油化学株式会社 | 2―(4―イソブチルフエニル)―2―ブテン |
AU644281B2 (en) | 1991-04-24 | 1993-12-02 | Sumitomo Pharmaceuticals Company, Limited | Novel thiazole derivatives |
JPH05286902A (ja) * | 1992-04-10 | 1993-11-02 | Sumitomo Pharmaceut Co Ltd | α−クロロ−β−ケトエステル誘導体の製造方法 |
IT1303249B1 (it) * | 1998-10-23 | 2000-11-06 | Dompe Spa | Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono. |
IT1317826B1 (it) * | 2000-02-11 | 2003-07-15 | Dompe Spa | Ammidi, utili nell'inibizione della chemiotassi dei neutrofiliindotta da il-8. |
-
2003
- 2003-12-09 PT PT03782344T patent/PT1581474E/pt unknown
- 2003-12-09 DK DK03782344T patent/DK1581474T3/da active
- 2003-12-09 EP EP03782344A patent/EP1581474B1/en not_active Expired - Lifetime
- 2003-12-09 DE DE60323264T patent/DE60323264D1/de not_active Expired - Lifetime
- 2003-12-09 ES ES03782344T patent/ES2312834T3/es not_active Expired - Lifetime
- 2003-12-09 JP JP2004558041A patent/JP5021169B2/ja not_active Expired - Fee Related
- 2003-12-09 US US10/537,824 patent/US20060247297A1/en not_active Abandoned
- 2003-12-09 AT AT03782344T patent/ATE406343T1/de active
- 2003-12-09 CA CA2507765A patent/CA2507765C/en not_active Expired - Fee Related
- 2003-12-09 SI SI200331435T patent/SI1581474T1/sl unknown
- 2003-12-09 WO PCT/EP2003/013946 patent/WO2004052830A1/en active IP Right Grant
- 2003-12-09 CN CNB200380107685XA patent/CN100383110C/zh not_active Expired - Fee Related
- 2003-12-09 RU RU2005121554/04A patent/RU2345759C2/ru not_active IP Right Cessation
- 2003-12-09 AU AU2003289993A patent/AU2003289993B8/en not_active Ceased
-
2005
- 2005-06-23 NO NO20053086A patent/NO332223B1/no not_active IP Right Cessation
-
2006
- 2006-07-14 HK HK06107858A patent/HK1085721A1/xx not_active IP Right Cessation
-
2008
- 2008-11-26 CY CY20081101364T patent/CY1108596T1/el unknown
- 2008-12-03 US US12/327,767 patent/US9328057B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP5021169B2 (ja) | 2012-09-05 |
RU2345759C2 (ru) | 2009-02-10 |
CY1108596T1 (el) | 2014-04-09 |
HK1085721A1 (en) | 2006-09-01 |
PT1581474E (pt) | 2008-12-09 |
US9328057B2 (en) | 2016-05-03 |
AU2003289993B2 (en) | 2008-04-24 |
AU2003289993A1 (en) | 2004-06-30 |
DK1581474T3 (da) | 2008-12-08 |
DE60323264D1 (de) | 2008-10-09 |
ES2312834T3 (es) | 2009-03-01 |
EP1581474A1 (en) | 2005-10-05 |
CA2507765C (en) | 2012-03-20 |
NO332223B1 (no) | 2012-07-30 |
EP1581474B1 (en) | 2008-08-27 |
ATE406343T1 (de) | 2008-09-15 |
CN1732145A (zh) | 2006-02-08 |
CA2507765A1 (en) | 2004-06-24 |
CN100383110C (zh) | 2008-04-23 |
NO20053086L (no) | 2005-06-23 |
AU2003289993B8 (en) | 2008-05-08 |
JP2006509022A (ja) | 2006-03-16 |
SI1581474T1 (sl) | 2009-02-28 |
WO2004052830A1 (en) | 2004-06-24 |
US20090203652A1 (en) | 2009-08-13 |
US20060247297A1 (en) | 2006-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2019537605A5 (ru) | ||
RU2403251C2 (ru) | Производные 2, 4-ди(гетеро)ариламинопиримидина в качестве ингибиторов zap-70 | |
RU2418792C2 (ru) | Азольные соединения с нейтротерапевтической активностью | |
RU2413727C2 (ru) | Производные пиразола и их применение в качестве ингибиторов рецепторных тирозинкиназ | |
RU2436776C2 (ru) | ДИАРИЛАМИН-СОДЕРЖАЩИЕ СОЕДИНЕНИЯ, КОМПОЗИЦИИ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ МОДУЛЯТОРОВ РЕЦЕПТОРОВ с-КIT | |
RU2326869C2 (ru) | Производные пиридазин-3(2h)-она в качестве ингибиторов фосфодиэстеразы 4 (pde4), способ их получения, фармацевтическая композиция и способ лечения | |
RU2009133259A (ru) | Производные пиразола в качестве ингибиторов 11-бета-hsd1 | |
RU2357959C2 (ru) | Получение и применение арилалкильных производных кислот для лечения ожирения | |
RU2356893C2 (ru) | Ингибиторы фосфодиэстеразы 4 | |
JP2007519754A5 (ru) | ||
RU2008112683A (ru) | Ингибиторы fap | |
RU2013117464A (ru) | Циклопропановые соединения | |
RU2005120146A (ru) | Производные миндальной кислоты | |
RU2013150811A (ru) | Ингибиторы идо | |
RU2003132687A (ru) | Лечение диабета типа 2 ингибиторами дипептидилпептидазы iv | |
JP2005522480A5 (ru) | ||
RU2013151174A (ru) | Замещенные пиримидинилпирролы, активные в качестве ингибиторов киназы | |
RU2008137526A (ru) | Ингибиторы киназы, основанные на гидантоине | |
RU2015144653A (ru) | Противовирусные соединения и их применения | |
RU2007147344A (ru) | Новые производные 2-азетидинона для лечения гиперлипидемических заболеваний | |
RU2007112688A (ru) | Производные 4-аминометилбензамина и их применение в качестве ингибиторов фактора viia | |
RU2002124136A (ru) | (r)-2-арилпропионамиды, полезные при ингибировании ил-8-индуцированного хемотаксиса нейтрофилов | |
JP2010523653A5 (ru) | ||
ATE482192T1 (de) | Pyrrolidinderivate zur behandlung einer von der reninaktivität abhängigen krankheit | |
JP2010532386A5 (ru) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC43 | Official registration of the transfer of the exclusive right without contract for inventions |
Effective date: 20151027 |
|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20191210 |